Valneva SE (VALN) bonds
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.57−0.08 (-1.50%)
Close on Nov 17, 2026Market cap $482.87MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
€184.06M
€18.43M due within a year
Net debt
€62.53M
After €121.53M of cash
Implied interest rate
22.86%
FY2025 interest ÷ average debt
Interest coverage
-2.0×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, EUR
Notes and loans outstanding
Individual notes, bonds and loans
Valneva's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?